Fig. 1. hPAF1C expression is a prognostic marker for early-stage NSCLC patients. A: representative positive and negative IHC staining of hPAF1 in clinical FFPE samples. B: The overall
survival (OS) curve analysis in 183 NSCLC patients grouped according to the hPAF1C expression level.